Avendus Pharmaceuticals Private Limited

Avendus Pharmaceuticals Private Limited - chemicals in Nashik, Maharashtra, India. FY 2026 financials & compliance.
CIN U74900MH2014PTC255818 Incorporated 03 July 2014 ROC Mumbai HQ Nashik, Maharashtra, India
Active Private Limited Company chemicals
Data last updated
Revenue · FY 2023
₹11.01 Lakh
▼ 57% YoY
Net profit · FY 2023
₹49,722
Net margin 4.5%
EBITDA · FY 2023
₹52,457
EBITDA margin 4.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
12 yrs
Est. 2014
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Avendus Pharmaceuticals Private Limited

Data last updated:

Avendus Pharmaceuticals Private Limited is a private limited company based in Nashik, Maharashtra, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 03 July 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74900MH2014PTC255818. Its GSTIN is 27AAMCA7070R1ZV (Maharashtra).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shainesh Sidhan Pullani and Siddharth Prakash Shah.

Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at S 1506 7 8 P 11 Islamppura Ward Malegaon, Nashik, Maharashtra, India – 423203.

As per the financials filed for FY 2023, the company reported a revenue of ₹11.01 Lakh, a decline of 57% compared to the previous year. For the same year it recorded a net profit of ₹49,722 (net margin 4.5%) and EBITDA of ₹52,457 (EBITDA margin 4.8%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 20% over five years.

The current compliance status is marked as active non-compliant by the Registrar of Companies.

Company Details of Avendus Pharmaceuticals Private Limited
CIN U74900MH2014PTC255818
Registration Number 255818
Incorporation Date 03 July 2014
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Non-Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    S 1506 7 8 P 11 Islamppura Ward Malegaon, Nashik, Maharashtra, India – 423203
  • Industry
    Chemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
Comprehensive company report
Avendus Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Avendus Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Avendus Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Avendus Pharmaceuticals Private Limited

The main business activity of Avendus Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Avendus Pharmaceuticals Private Limited FY 2023 filings available

Avendus Pharmaceuticals Private Limited reported revenue of ₹11.01 Lakh (down 57% YoY) for FY 2023.

Revenue · FY 2023
₹11.01 Lakh ▼ 57%
Net profit · FY 2023
₹49,722 margin 4.5%
EBITDA · FY 2023
₹52,457 margin 4.8%

Compounded Annual Growth Rate (CAGR) of Avendus Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▼ 57%
3 years · compounded
▼ 11%
5 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▼ 55%
3 years · compounded
▲ 105%
5 years · compounded
▲ 73%

Revenue fell 57% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 20%. EBITDA fell 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Avendus Pharmaceuticals Private Limited

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹52,457••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹49,722••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Avendus Pharmaceuticals Private Limited

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin4.8%••••••••••••••••
Net Profit Margin4.5%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Avendus Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Avendus Pharmaceuticals Private Limited

Avendus Pharmaceuticals has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Shainesh Sidhan PullaniDirector03 Jul 201412 Years 3 MonthsCurrent
Siddharth Prakash ShahDirector03 Jul 201412 Years 3 MonthsCurrent
Sandesh Bipin GujarathiDirector03 Jul 201412 Years 3 MonthsCurrent

Peer Comparison of Avendus Pharmaceuticals Private Limited

Avendus Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Lion in Pharmaceuticals India Private Limited₹11.13 Lakh (FY 2025)••••••••-22.0%••••Yelahanka, Karnataka, India
HCLK Pharmaceuticals Private Limited₹11.11 Lakh (FY 2025)••••••••19.0%••••Delhi, India
Medsci Pharmaceuticals Private Limited₹11.11 Lakh (FY 2025)••••••••••••Varanasi, Uttar Pradesh, India
Medbro 5 India Pharmaceuticals Private Limited₹11.04 Lakh (FY 2025)••••••••-21.0%••••Pune, Maharashtra, India
Utrint Pharmaceuticals Private Limited₹11.03 Lakh (FY 2025)••••••••21.0%••••Beed, Maharashtra, India
Avendus Pharmaceuticals Private Limited this company₹11.01 Lakh (FY 2023)••••••••-57.0%••••Nashik, Maharashtra, India
Icure Pharmaceuticals Private Limited₹11.01 Lakh (FY 2025)••••••••-84.0%••••Guntur, Andhra Pradesh, India
Indoraggu Pharmaceuticals Private Limited₹11 Lakh (FY 2024)••••••••-45.0%••••Mysore, Karnataka, India
BTL Pharmaceuticals Private Limited₹10.97 Lakh (FY 2024)••••••••-15.0%••••Chennai, Tamil Nadu, India
Unihex Pharmaceuticals Private Limited₹10.96 Lakh (FY 2022)••••••••45.0%••••Hyderabad, Telangana, India
Davion Pharmaceuticals (P) Ltd.₹10.93 Lakh (FY 2022)••••••••-42.0%••••Agra, Uttar Pradesh, India

Peers are the five companies nearest above and the five nearest below Avendus Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Avendus Pharmaceuticals Private Limited

Avendus Pharmaceuticals Private Limited is audited by HARSHAD AGRAWAL for the financial year 2017.

NameStatusAppointment DateCessation Date
HARSHAD AGRAWALLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Avendus Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Avendus Pharmaceuticals Private Limited

Avendus Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Avendus Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Avendus Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Avendus Pharmaceuticals Private Limited

Avendus Pharmaceuticals Private Limited has 3 board changes on record since 2014: 3 appointments. The latest: Sandesh Bipin Gujarathi was appointed as Director on 03 Jul 2014.

AGM
Avendus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Avendus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai Ii.
Appointed
Sandesh Bipin Gujarathi was appointed as Director.
Appointed
Shainesh Sidhan Pullani was appointed as Director.
Appointed
Siddharth Prakash Shah was appointed as Director.
Incorporation
03 Jul 2014
Avendus Pharmaceuticals Private Limited was registered on 03 Jul 2014 with Roc Mumbai Ii & aged 12 years 3 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Avendus Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Avendus Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Avendus Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Avendus Pharmaceuticals Private Limited

Avendus Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAMCA7070R1ZVMaharashtraActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Avendus Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Avendus Pharmaceuticals Private Limited

Avendus Pharmaceuticals is an active private limited company based in Nashik, Maharashtra, India. The company works in chemical products, within the chemicals industry. It was incorporated on 03 July 2014 (12+ years old) and is registered under CIN U74900MH2014PTC255818.

Avendus Pharmaceuticals reported revenue of ₹11.01 Lakh for FY 2023 (down 57% YoY).

Avendus Pharmaceuticals has 3 current directors:

Avendus Pharmaceuticals reported a net profit of ₹49,722 (net margin 4.5%) and EBITDA of ₹52,457 (EBITDA margin 4.8%) for FY 2023, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Avendus Pharmaceuticals is -11% over three years and 20% over five years. In the latest year (FY 2023) revenue fell 57%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Avendus Pharmaceuticals is 27AAMCA7070R1ZV, registered in Maharashtra.

The CIN (Corporate Identification Number) of Avendus Pharmaceuticals is U74900MH2014PTC255818. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Avendus Pharmaceuticals was incorporated on 03 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Avendus Pharmaceuticals by revenue are Lion in Pharmaceuticals India Private Limited, HCLK Pharmaceuticals Private Limited, Medsci Pharmaceuticals Private Limited, Medbro 5 India Pharmaceuticals Private Limited, Utrint Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).

Sandesh Bipin Gujarathi was appointed as Director on 03 Jul 2014. Shainesh Sidhan Pullani was appointed as Director on 03 Jul 2014. Siddharth Prakash Shah was appointed as Director on 03 Jul 2014.

The registered office of Avendus Pharmaceuticals is at S 1506 7 8 P 11 Islamppura Ward Malegaon, Nashik, Maharashtra, India – 423203.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available